4:05 PM ET
8-K
Court & Legal Update
Collegium Pharmaceutical Court & Legal Update
Collegium Pharmaceutical entered into a settlement agreement with Grünenthal GmbH to resolve patent infringement litigation related to Nucynta ER. As part of the settlement, Collegium will pay $17 million to terminate a 2015 license agreement and discharge all future royalty obligations. Additionally, Grünenthal assigned certain Nucynta-related patents to Collegium and moved to dismiss the pending lawsuit.
- Counterparty
- Grünenthal GmbH